系统性硬化症患者用力肺活量测量质量的评估
这项横断面研究纳入98例系统性硬化症(SSc)患者和100名年龄性别匹配对照,按美国胸科学会(ATS)与欧洲呼吸学会(ERS)更新指南对用力肺活量(FVC)测量质量分级。SSc患者高质量FVC测量率显著低于对照(80% vs 60.2%,P=0.002);弥漫性疾病、间质性肺病、抗拓扑异构酶1抗体阳性、免疫抑制使用、手屈曲挛缩、张口受限和胸廓扩张度减低在低质量FVC患者中更常见(均P<0.05)。
要点
- SSc患者高质量FVC测量率显著低于年龄性别匹配对照(80% vs 60.2%,P=0.002)。
- 弥漫性疾病、间质性肺病、抗拓扑异构酶1抗体阳性、免疫抑制使用、手屈曲挛缩、张口受限和胸廓扩张度减低与低质量FVC相关(均P<0.05)。
- 存在一种以上可能影响FVC质量的情况在低质量FVC患者中显著更多。
核心结论
- 相当比例的SSc患者FVC测量质量低,医生在解读FVC结果时应意识到这一点,尤其是存在一种以上可能影响测试质量的情况时。
研究设计与样本
- 横断面研究纳入98例SSc患者(90例女性)和100名年龄性别匹配对照,均接受肺量计检查,按ATS与ERS更新指南对FVC测量质量分级。
主要发现
- SSc患者高质量FVC测量率显著低于对照(80% vs 60.2%,P=0.002)。
- SSc患者中,弥漫性疾病、间质性肺病、抗拓扑异构酶1抗体阳性、免疫抑制使用、手屈曲挛缩、张口受限和胸廓扩张度减低在低质量FVC患者中更常见(均P<0.05)。
- 肌肉无力和中/高营养不良风险在低质量FVC组中数值上更高。
- 存在一种以上可能影响FVC质量的情况在低质量FVC患者中显著更多。
关键数值与推荐
- FVC测量质量按ATS与ERS更新指南分级。
- 高质量FVC测量率:SSc患者60.2% vs 对照80%(P=0.002)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Forced vital capacity (FVC) is an important tool for monitoring lung functions in patients with systemic sclerosis (SSc). However, several disease manifestations may influence the quality of FVC test in SSc. We aimed to assess the quality of FVC measurements according to current guidelines in patients with SSc and determine the factors that may affect results. METHOD: In this cross-sectional study, SSc patients and age/sex matched controls underwent spirometry. Quality of FVC measurements were graded according to updated American Thoracic Society (ATS) and European Respiratory Society (ERS) guidelines. Demographics, clinical features and parameters that may affect FVC test quality were compared between SSc patients with high and low quality FVC test. RESULTS: 98 SSc patients (90 female) and 100 controls were included. The rate of high quality FVC measurement in SSc patients was significantly lower in SSc patients compared to controls. (80 % vs 60.2 % p = 0.002). Among SSc patients; diffuse disease, ILD, anti-topoisomerase 1 antibody positivity, immunosuppressive use, flexion contractures of hands, reduced mouth opening and decreased chest expansion were more frequent in patients with low quality FVC (p < 0.05 for all). Patients with muscle weakness and medium/high risk of malnutrition were also numerically higher in low quality FVC group. Presence of more than one condition that may affect FVC quality was significantly higher among patients with low quality FVC. CONCLUSION: A significant percent of SSc patients had low quality FVC measurement. Physicians should be aware of this point while interpreting FVC test results especially in SSc patients with more than one condition that may affect the quality of the test.
引用
- Uzun GS, Sarı A, Karcıoğlu O, et al. Assessing the quality of forced vital capacity measurement in patients with systemic sclerosis. Semin Arthritis Rheum. 2024. PMID: 38823336. doi:10.1016/j.semarthrit.2024.152466
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。